从苦毒素到生物活性资产:重新定义Lupinus spp中的诺化类化物
Hajer Ben Ammar1, Barbara Pipan1, Lovro Sinkovič1
1Crop Science Department, Agricultural Institute of Slovenia, SI-1000 Ljubljana, Slovenia.
Food research international (Ottawa, Ont.)
|March 12, 2026
概括
狼中的诺化 (QAs) 由于毒性和苦味,对食品使用构成挑战. 研究正在探索它们的潜在生物活性和改进的加工方法,以更安全,更可持续地将狼融入饮食中.
科学领域:
- 农业科学 农业科学
- 食品科学 食品科学 食品科学
- 植物生物化学 植物生物化学
背景情况:
- 狼 (Lupinus spp.) 是一种类植物. 是气候适应性豆类,蛋白质含量高,对可持续的粮食系统有价值.
- 奎诺利兹类类化合物 (QA) 限制了狼的消费,因为毒性和苦,尽管在低度下可能对健康有益.
研究的目的:
- 审查最近在了解狼类诺利齐丁类化物 (QA) 的进展.
- 探索QA化学,生物合成,分析方法,毒理学,加工和生物活性.
- 确定狼利用的挑战和未来研究方向.
主要方法:
- 文献综述综合了对狼的QA最近的发现.
- 分析高分辨率技术,代谢学和新型加工方法的进步.
- 质量保证化学,生物合成,分析协议和毒理学的批判性评估.
主要成果:
- 扩大了QA的结构知识和改进了化学型化能力.
- 开发加工技术,以高效地去除QA和潜在的化物.
- 在亚毒度下识别QA的新兴生物活性.
结论:
- 可持续地整合狼需要将重点从仅仅消除QA转向受控调制和价值化.
- 标准化的分析协议,定义的感觉值,明确的规定和临床验证对于狼的食品应用至关重要.
- 未来的研究应该优先考虑释放QAs对狼的功能潜力,作为安全的多功能作物.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
2.1K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.1K
Drugs for Treatment of Diarrhea-Predominant IBS
832
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
832
Drugs that Destabilize Microtubules
4.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
891
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
891


